These authors claimed that a certain degree of tau pathology in the monoaminergic tract could represent the substrate for more intense neurodegeneration in AD cases (Attems et al., 2007, 2012; Simic et al., 2009; Trillo et al., 2013). The gene discussed is MAPT; the disease is Alzheimer disease.